Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05128890 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Resection Techniques for Pancreatic Tumors

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates: Apr 26, 2026 to Apr 26, 2027v7
  2. Notable Primary and study completion dates: Apr 26, 2025 to Apr 26, 2026
    • Site contact updated
    v6
  3. Notable Trial status: Active, Not Recruiting to Recruitingv5 Show 6 more changesShow less
    • Enrollment target: 250 to 431
    • Primary and study completion dates: May 26, 2024 to Apr 26, 2025
    • Start date: Mar 1, 2023 to Apr 16, 2016
    • Site details revised
    • Eligibility criteria shortened, about 3 words
    • Study description shortened, about 1 word
  4. Notable Primary and study completion dates: May 25, 2023 to May 26, 2024
    • Start date: May 26, 2016 to Mar 1, 2023
    • Study sites: 0 to 1
    v4
  5. Notable Primary and study completion dates: May 25, 2022 to May 25, 2023v3
  6. Minor Study description shortened, about 150 wordsv2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.
Trial Details
NCT Number NCT05128890
Lead Sponsor Methodist Health System
Conditions
(from sponsor)
Surgery, Liver Tumor, Pancreas Tumor
Related terms Carcinoma, Hepatocellular, Pancreatic Neoplasms
Enrollment 431 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov